| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/05/2011 | US7919648 Lateral α-substituted acrylate compound and polymer thereof |
| 04/05/2011 | US7919615 Route to formyl-porphyrins |
| 04/05/2011 | US7919528 Antibiotic; bactericides |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919197 Condensed ring aromatic compound and organic light-emitting device having the same |
| 04/05/2011 | US7918976 Transition metal complexes with bidentate ligand having an imidazole ring |
| 04/05/2011 | CA2476350C Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| 04/05/2011 | CA2475434C Aromatic amino acid derivatives and medicinal compositions |
| 04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 04/05/2011 | CA2360326C Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 03/31/2011 | WO2011037947A1 Synthesis of (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester and intermediates thereof |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011036648A1 Polymorphs of sorafenib acid addition salts |
| 03/31/2011 | WO2011036647A1 Process for the preparation of sorafenib tosylate |
| 03/31/2011 | WO2011036557A1 Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles |
| 03/31/2011 | WO2011000464A3 Continuous method for producing esters of aromatic carboxylic acids |
| 03/31/2011 | WO2010144499A3 Urea derivatives as kinase inhibitors |
| 03/31/2011 | WO2010142616A3 Deprotection of boc-protected compounds |
| 03/31/2011 | WO2010106166A3 Radiolabelled pyridinyl derivatives for in-vivo imaging |
| 03/31/2011 | US20110077407 Functionalized Polymers Using Protected Thiols |
| 03/31/2011 | US20110077406 Cross-coupling of phenolic derivatives |
| 03/31/2011 | US20110077395 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 03/31/2011 | US20110077251 Novel 17 beta lupane derivatives |
| 03/31/2011 | US20110077160 Pesticides |
| 03/31/2011 | CA2775397A1 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| 03/31/2011 | CA2775296A1 Polymorphs of sorafenib acid addition salts |
| 03/31/2011 | CA2775229A1 Process for the preparation of sorafenib tosylate |
| 03/31/2011 | CA2774647A1 Substituted amide compound |
| 03/31/2011 | CA2774614A1 Synthesis of (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester and intermediates thereof |
| 03/30/2011 | EP2301939A1 Enzyme inhibitors |
| 03/30/2011 | EP2301934A1 Nitrocatechol derivatives as COMT inhibitors |
| 03/30/2011 | EP2301923A1 New compounds |
| 03/30/2011 | EP2301922A1 Pyridone compound |
| 03/30/2011 | EP2301914A1 7,9-Substituted tetracycline compounds |
| 03/30/2011 | EP2301913A1 7,9-Substituted tetracycline compounds |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2300433A1 Hiv integrase inhibitors from pyridoxine |
| 03/30/2011 | EP2300432A1 Piperazine derivatives used as cav2.2 calcium channel modulators |
| 03/30/2011 | EP2300431A1 Process for the manufacture of an intermediate in the synthesis of dabigatran |
| 03/30/2011 | EP2300430A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/30/2011 | EP2300429A1 Gas-phase process for the synthesis of diaminopyridines from glutaronitriles |
| 03/30/2011 | EP2300428A1 Aminopyridine derivatives |
| 03/30/2011 | EP2300427A1 Urea compounds as gamma secretase modulators |
| 03/30/2011 | EP2300426A1 Compounds comprising a cyclobutoxy group |
| 03/30/2011 | EP2178513B1 Tableted compositions containing atazanavir |
| 03/30/2011 | EP2125736B1 Substituted acetophenones useful as pde4 inhibitors |
| 03/30/2011 | EP1907360B1 Improved process for the manufacture of flecainide |
| 03/30/2011 | EP1838674B1 Heteroaryl sulfonamides and ccr2 |
| 03/30/2011 | EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 03/30/2011 | EP1601643B1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments |
| 03/30/2011 | EP0933354B1 Calcium receptor-active compounds |
| 03/30/2011 | CN1980666B Process for preparing atazanavir bisulfate and novel forms |
| 03/30/2011 | CN1898210B 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 03/30/2011 | CN1876664B Organometallic complex and organic electroluminescent device using the same |
| 03/30/2011 | CN101993418A (Methyl) acrylamido carboxylate ionic liquid and preparation method thereof |
| 03/30/2011 | CN101993415A Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof |
| 03/30/2011 | CN101993414A Method for preparing 2-mercaptopyridine |
| 03/30/2011 | CN101993413A Method for preparing 4-pyridine propyl alcohol |
| 03/30/2011 | CN101993392A Multi-cyano substituted triphenylamine derivatives and synthesis method and use thereof |
| 03/30/2011 | CN101993382A 芳香胺类衍生物或其类似物及其应用 Aromatic amine derivatives or analogues thereof and its application |
| 03/30/2011 | CN101440286B Compound polymerization inhibitor and uses thereof |
| 03/30/2011 | CN101302191B Synthetic method of 3- formyl- halogenated pyridine-2(1H)-ketones compound |
| 03/30/2011 | CN101279969B Organic electroluminescent material and application thereof |
| 03/30/2011 | CN101133027B Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 03/29/2011 | US7915450 Transfection reagents |
| 03/29/2011 | US7915424 Analgesics; anxiolytic agents |
| 03/29/2011 | US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases |
| 03/29/2011 | US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 03/29/2011 | US7914905 π-conjugated aromatic ring-containing compound and organic electroluminescent device |
| 03/29/2011 | US7914706 Charge transport compositions and electronic devices made with such compositions |
| 03/29/2011 | CA2641877C Improved process for producing nitroguanidine derivatives |
| 03/29/2011 | CA2580843C Control of parasites in animals by the use of trifluoromethanesulfonanilide oxime ether derivatives |
| 03/29/2011 | CA2497237C N-substituted-2-oxodihydropyridine derivatives |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2474208C Astaxanthin esters |
| 03/29/2011 | CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/29/2011 | CA2460640C Diaryl ether derivatives, salts thereof and immunosuppressive agents using the same |
| 03/29/2011 | CA2428223C Compounds and methods for promoting smoking cessation |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011033045A1 Heterocyclic antiviral compounds |
| 03/24/2011 | WO2011033010A1 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases |
| 03/24/2011 | WO2011033009A1 N- [2-hydroxycarbamoyl-2- (piperazinyl) ethyl] benzamide compounds, their preparation and their use as tace inhibitors |
| 03/24/2011 | WO2011032692A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| 03/24/2011 | WO2011032277A1 Quinazolinone derivatives as viral polymerase inhibitors |
| 03/24/2011 | WO2011032269A1 Cyclometalated dye complexes and their use in dye-sensitized solar cells |
| 03/24/2011 | WO2010142678A3 Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide |
| 03/24/2011 | WO2010091384A3 Cadherin-11 inhibitors and methods of use thereof |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071178 Methods and Compounds for Modulating Cannabinoid Activity |
| 03/24/2011 | US20110071127 Compounds Which Modulate the CB2 Receptor |
| 03/24/2011 | US20110071099 Cationic Ceramides, And Analogs Thereof, And Their Use For Preventing Or Treating Cancer |
| 03/24/2011 | US20110071093 Novel Reagents |
| 03/24/2011 | CA2774981A1 O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators |
| 03/24/2011 | CA2774018A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazo[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| 03/24/2011 | CA2773985A1 Protein kinase conjugates and inhibitors |
| 03/24/2011 | CA2773832A1 Compounds useful against kinetoplastideae parasites |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/24/2011 | CA2771679A1 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases |
| 03/24/2011 | CA2771168A1 N-[2-hydroxycarbamoyl-2-(piperazinyl)ethyl]benzamide compounds, their preparation and their use as tace inhibitors |